Effectiveness and safety of the use of sodium nitrite in patients with hypertension and pulmonary hypertension: a scoping review
Authors:
- Jéssyca Milene RibeiroJRJéssyca Milene Ribeiro
- Aleksander Brandão SantanaASAleksander Brandão Santana
- Letícia de Oliveira MarussoLMLetícia de Oliveira Marusso
- Danielle Aparecida Ferreira de Oliveira MarrafonDMDanielle Aparecida Ferreira de Oliveira Marrafon
- Tiago Marques dos ReisTRTiago Marques dos Reis
- Pedro Luiz RosalenPRPedro Luiz Rosalen
- Larissa Helena Lobo TorresLTLarissa Helena Lobo Torres
- José Eduardo Tanus-SantosJosé Eduardo Tanus-Santos
- Carla Speroni CeronCCCarla Speroni Ceron
- 28 January 2025
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 398 (6) , 6561-6577
Abstract
Evidence suggests that sodium nitrite may be effective in the treatment of hypertension and pulmonary hypertension. However, its use remains debated due to safety concerns. In response, a scoping review was conducted to map current knowledge on the efficacy and safety of sodium nitrite in patients with hypertension or pulmonary hypertension, addressing the question: What evidence supports the effectiveness and safety of using sodium nitrite in these patients? The databases MEDLINE (PubMed), EMBASE, Scopus, Web of Science, and LILACS were searched for clinical studies on hypertensive patients at any disease stage without restrictions on age, sex, ethnicity, publication date, or status. The primary outcomes analyzed were the efficacy and safety of sodium nitrite. A total of nine articles were included, eight from databases and one from gray literature. Sample sizes ranged from 5 to 36 patients, with sodium nitrite doses between 240 µg/kg/h and 325 mg. Five studies showed positive results for treating essential hypertension. Regarding safety, only one study raised concerns about adverse effects, probably due to the high dose that was used. In pulmonary hypertension patients classified as groups 2, 3, and 5, four studies suggested sodium nitrite was effective and safe, but it was ineffective in group 1. The studies included several significant limitations that should be considered. As such, the current evidence is insufficient to definitively confirm the efficacy and safety of sodium nitrite in hypertensive patients. Further research with larger sample sizes is necessary to obtain more conclusive results.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior” (001)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (302076/2022‐0 and 406442/2022-3, 302076/2022‐0 and 406442/2022-3)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (APQ‐00946‐23)
This publication has 41 references indexed in Scilit:
- The effect and mechanism of combined exposure of MC-LR and NaNO2 on liver lipid metabolismEnvironmental Research, 2024
- Pulmonary arterial hypertensionLa Presse Médicale, 2023
- Animal models of hypertension: The status of nitric oxide and oxidative stress and the role of the renal medullaNitric Oxide, 2022
- Efficacy and safety of inhaled nitrite in addition to sildenafil in thalassemia patients with pulmonary hypertension: A 12-week randomized, double-blind placebo-controlled clinical trialNitric Oxide, 2022
- Relationship between endothelin and nitric oxide pathways in the onset and maintenance of hypertension in children and adolescentsPediatric Nephrology, 2021
- The Effects of Inhaled Sodium Nitrite on Pulmonary Vascular Impedance in Patients With Pulmonary Hypertension Associated with Heart Failure With Preserved Ejection FractionJournal of Cardiac Failure, 2020
- Sample Size Estimation in Clinical ResearchChest, 2020
- Inhaled nebulized sodium nitrite decreases pulmonary artery pressure in β-thalassemia patients with pulmonary hypertensionNitric Oxide, 2018
- Endothelial Dysfunction and Hypertension2016
- INFLUENCE OF SODIUM NITRITE ON THE CARDIOVASCULAR SYSTEM AND ON RENAL ACTIVITYArchives of internal medicine (1908), 1933